Promoter in gastric cancer in association with α3 integrins.Promoter in breast cancer in association with integrins promoting a signaling pathway (HGF/c-MET).Promoter in liver cancer by increasing Rac/Cdc42 activity. This evidence concerns the gene MET and breast carcinoma.